Education
About Us
Working with TipRanks
Follow Us
Brii Biosciences Limited (HK:2137)
:2137
Brii-835 (Vir-2218), Brii-179, Peg-Ifnα
Chronic Hepatitis B Virus (Hbv) Infection
Phase II
Recruiting
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
Oct 12, 2024
―
Brii-835 (Vir-2218), Brii-179, Peg-Ifnα
For Treatment Of Chronic Hepatitis B Virus Infection
Phase II
Active Not Recruiting
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)
Jun 28, 2024
―
Brii-296, Depo Medrol
Severe Postpartum Depression
Phase II
Completed
A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
Sep 21, 2023
―
Peg-Ifnα, Brii-835
Chronic Hepatitis B Virus Infection
Phase II
Active Not Recruiting
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
Jul 21, 2023
―
Brii-297
Postpartum Depression
Phase I
Completed
A Study of BRII-297 in Healthy Adult Subjects
Apr 12, 2023
―
Brii-196 And Brii-198
Covid-19
Phase II
Completed
A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
Mar 04, 2021
―
Brii-835 (Vir-2218), Brii-179 (Vbi-2601) With Ifn-Α, Brii-179 (Vbi-2601)
Hepatitis B, Chronic
Phase II
Completed
Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection
Feb 07, 2021
―
Brii-196 And Brii-198
Covid-19
Phase I
Completed
A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
Dec 17, 2020
―
Vir-2218
Hepatitis B, Chronic
Phase II
Completed
Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China
Aug 07, 2020
―
Brii-196
Covid-19
Phase I
Completed
Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196
Jul 14, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Brii Biosciences Limited (2137) have in its pipeline
2137 is currently developing the following drugs: Brii-835 (Vir-2218), Brii-179, Peg-Ifnα, Brii-835 (Vir-2218), Brii-179, Peg-Ifnα, Brii-296, Depo Medrol. These drug candidates are in various stages of clinical development as the company works toward FDA approval.